The next version of the DSM is being planned with some potentially major changes. Will we get a giant leap forward or just ...

Ozempic isn’t the only drug that mimics the natural GLP-1 hormone, so users feel fuller for longer and eat less. There’s also Zepbound, Mounjaro, Trulicity and Victoza — and many more on the horizon ...

A majority of respondents (67%) say Congress did the “wrong thing” by not yet extending the ACA enhanced premium tax credits, ...

Alabama’s central data repository enables coordinated action across health, law enforcement and governmental agencies.

A study showed that firearm injuries among parents were associated with increased rates of psychiatric disorder diagnoses and ...

Otsuka Pharmaceutical announced that the FDA is reviewing investigational centanafadine -- a potential first-in-class ...

Home Office ministers asked their official drugs advisers to look at increasing ketamine from Class B to Class A after its ...

OHSU counters that project is not done—and that judging use metrics at this point would be like tracking traffic on a road that is not yet complete.

A chef known for his obsessive approach to fried chicken is trying to change his relationship to his restaurant - and himself.

The current edition of the Diagnostic and Statistical Manual is known as the DSM-5. What will the next version be called?

The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...

Epilepsy is a complex neurological disorder characterized by spontaneous recurrent seizures, affecting approximately 50 ...